NeuroPace Seeks $75M In IPO
Executive Summary
The California neuromodulation company filed a registration with the US Securities and Exchange Commission to sell common stock on NASDAQ under the ticker NPCE.
You may also be interested in...
NeuroPace Raises $67M To Help Commercialize RNS System For Epilepsy
The latest financing round will also support a new clinical trial of the RNS system for children with epilepsy.
AMA Establishes Principles For ‘Augmented Intelligence’
The American Medical Association has written a set of principles for augmented intelligence (AI) development and deployment in health care. The organization hopes these principles can shape “a consistent governance structure for advancements in health care technology.”
News We’re Watching: Boston Scientific Closes Relievant, Medtronic's PFA Earns CE Mark, And More
Medtech Insight's News We're Watching highlights medtech industry news developments you may have missed over the last few weeks.